Correlation Between Pasithea Therapeutics and Biofrontera

Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Biofrontera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Biofrontera into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pasithea Therapeutics Corp and Biofrontera, you can compare the effects of market volatilities on Pasithea Therapeutics and Biofrontera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Biofrontera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Biofrontera.

Diversification Opportunities for Pasithea Therapeutics and Biofrontera

-0.32

Correlation Coefficient

Pasithea Therapeutics  Biofrontera

Very good diversification

The 3 months correlation between Pasithea and Biofrontera is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Biofrontera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Biofrontera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Biofrontera go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Biofrontera

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 36.99 times more return on investment than Biofrontera. However, Pasithea Therapeutics is 36.99 times more volatile than Biofrontera. It trades about 0.29 of its potential returns per unit of risk. Biofrontera is currently generating about 0.05 per unit of risk. If you would invest  1.11  in Pasithea Therapeutics Corp on September 26, 2024 and sell it today you would earn a total of  1.19  from holding Pasithea Therapeutics Corp or generate 107.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	47.2%
Values	Daily Returns

Pasithea Therapeutics Corp  vs.  Biofrontera

Pasithea Therapeutics

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly unsteady basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Biofrontera

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biofrontera has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Biofrontera is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Pasithea Therapeutics and Biofrontera

The main advantage of trading using opposite Pasithea Therapeutics and Biofrontera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Biofrontera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will offset losses from the drop in Biofrontera's long position.

The idea behind Pasithea Therapeutics Corp and Biofrontera pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.